TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$3.71B
1-Year Return
19.93%
This Quarter Return
+10.28%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$5.78B
AUM Growth
+$1.86B
(+48%)
Cap. Flow
+$1.56B
Cap. Flow
% of AUM
26.98%
Top 10 Holdings %
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,123
Increased
2,719
Reduced
2,325
Closed
681
Top Buys
| 1 |
Apple
AAPL
|
+$132M |
| 2 |
Microsoft
MSFT
|
+$129M |
| 3 |
Amazon
AMZN
|
+$89.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$71.7M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$51.8M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$418M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$84.8M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$43.2M |
| 4 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$36.3M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$20.9M |
Sector Composition
| 1 | Technology | 25.13% |
| 2 | Consumer Discretionary | 10.53% |
| 3 | Financials | 9.89% |
| 4 | Healthcare | 8.91% |
| 5 | Communication Services | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
ArcBest
ARCB
$1.6B
| $238K | ﹤0.01% |
1,993
-4,463
| -69% | -$533K |
|
1627
Endava
DAVA
$537M
| $238K | ﹤0.01% |
1,419
-263
| -16% | -$44.1K |
|
1628
Editas Medicine
EDIT
$242M
| $238K | ﹤0.01% |
8,990
+2,786
| +45% | +$73.8K |
|
1629
Sonos
SONO
$1.83B
| $238K | ﹤0.01% |
7,972
+692
| +10% | +$20.7K |
|
1630
iRobot
IRBT
$107M
| $237K | ﹤0.01% |
3,607
+2,706
| +300% | +$178K |
|
1631
Regenxbio
RGNX
$465M
| $237K | ﹤0.01% |
7,251
-423
| -6% | -$13.8K |
|
1632
Park National Corp
PRK
$2.72B
| $236K | ﹤0.01% |
1,720
+72
| +4% | +$9.88K |
|
|
KRA
1633
DELISTED
Kraton Corporation
KRA
| $236K | ﹤0.01% |
5,094
+2,848
| +127% | +$132K |
|
|
CMRC
1634
Commerce.com, Inc. Series 1 Common Stock
CMRC
$370M
| $234K | ﹤0.01% |
6,615
+2,818
| +74% | +$99.7K |
|
1635
Coeur Mining
CDE
$9.98B
| $234K | ﹤0.01% |
46,425
+30,882
| +199% | +$156K |
|
1636
CRISPR Therapeutics
CRSP
$5.12B
| $234K | ﹤0.01% |
3,085
+173
| +6% | +$13.1K |
|
1637
Relay Therapeutics
RLAY
$688M
| $234K | ﹤0.01% |
7,609
-1,131
| -13% | -$34.8K |
|
1638
ATI
ATI
$10.5B
| $233K | ﹤0.01% |
14,656
+1,637
| +13% | +$26K |
|
1639
Core & Main
CNM
$9.28B
| $233K | ﹤0.01% |
7,669
+6,893
| +888% | +$209K |
|
1640
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$3.72B
| $233K | ﹤0.01% |
8,153
+7,564
| +1,284% | +$216K |
|
1641
SPDR MSCI USA Gender Diversity ETF
SHE
$274M
| $233K | ﹤0.01% |
2,287
-188
| -8% | -$19.2K |
|
1642
Pacer US Small Cap Cash Cows 100 ETF
CALF
$4.1B
| $232K | ﹤0.01% |
5,428
+2,686
| +98% | +$115K |
|
1643
Schwab US Mid-Cap ETF
SCHM
$12.2B
| $232K | ﹤0.01% |
8,643
-43,077
| -83% | -$1.16M |
|
1644
Fate Therapeutics
FATE
$111M
| $231K | ﹤0.01% |
3,946
+291
| +8% | +$17K |
|
|
MOMO
1645
Hello Group
MOMO
$1.19B
| $231K | ﹤0.01% |
25,715
+7,152
| +39% | +$64.2K |
|
1646
Rocket Pharmaceuticals
RCKT
$341M
| $231K | ﹤0.01% |
10,589
+1,938
| +22% | +$42.3K |
|
|
MMP
1647
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $231K | ﹤0.01% |
4,964
+2,039
| +70% | +$94.9K |
|
1648
Twist Bioscience
TWST
$1.53B
| $230K | ﹤0.01% |
2,965
+2,643
| +821% | +$205K |
|
|
ARGO
1649
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $230K | ﹤0.01% |
3,960
+586
| +17% | +$34K |
|
|
KDNY
1650
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $230K | ﹤0.01% |
14,127
+9,430
| +201% | +$154K |
|